Search | IOVS | ARVO Journals

iovs

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Journals Home

SIGN IN

Forgot password?

Create an Account

To View More...

Purchase this article with an account.

or

Subscribe Now

Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Narrow View

NARROW

Content Type

Meeting Abstract (10)
Journal Articles (1)

Journal

Investigative Ophthalmology & Visual Science (11)

Article Type

ARVO Annual Meeting Abstract (10)
Retinal Cell Biology (1)

Topics

Eye Anatomy and Disorders (1)
Genetics (1)
Immunology and Microbiology (1)
Retina (1)
Retinal Cell Biology (1)

Tags

actins (1)
combined modality therapy (1)
retinal pigment cell (1)
rna-seq (1)
wounds and injuries (1)

Specify Date Range

From: To: Apply

Showing 1 – 11 of 11

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

Retinal Cell Biology August 2020

Risuteganib Protects against Hydroquinone–induced Injury in Human RPE Cells

PDF

Ping Yang; Zixuan Shao; Nicholas A. Besley; Samantha E. Neal; Kristen L. Buehne; John Park; Hampar Karageozian; Vicken Karageozian; Ian T. Ryde; Joel N. Meyer; Glenn J. Jaffe
TAGS: combined modality therapy, retinal pigment cell, wounds and injuries, actins, rna-seq
Invest. Ophthalmol. Vis. Sci.. 2020; 61(10):35. doi: https://doi.org/10.1167/iovs.61.10.35

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2020

Risuteganib Modifies Hydroquinone-regulated Gene Expression and Protects against Hydroquinone-induced Cytotoxic Effects in Human RPE Cells

Ping Yang; Zixuan Shao; Nicholas Besley; John Y Park; Hampar Karageozian; Vicken Karageozian; Glenn J Jaffe

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3117. doi:

ARVO Annual Meeting Abstract June 2020

Safety and Efficacy of Risuteganib in Intermediate Non-exudative Age-Related Macular Degeneration

Raj Maturi; Glenn J Jaffe; Justis P Ehlers; Peter K Kaiser; David S Boyer; Jeffrey S Heier; Julia A Kornfield; Baruch D Kuppermann; Hugo Quiroz-Mercado; Janine Aubel; Lisa Karageozian; Vicken H Karageozian; Melvin Sarayba

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):1944. doi:

ARVO Annual Meeting Abstract June 2020

Mechanism of Action of Risuteganib for Retinal Diseases through Protection of Retinal Pigment Epithelium (RPE) and Enhancement of Mitochondrial Functions

Dan Zhou; Marilyn Chwa; Zixuan Shao; Jin Mo Koo; John Y Park; Hampar L Karageozian; Vicken H Karageozian; Cristina M Kenney; Julia A Kornfield

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4949. doi:

ARVO Annual Meeting Abstract July 2018

Cytoprotective effect of ALG-1001 peptide (Luminate) on human retinal pigment epithelial cells exposed to oxidative injury. A novel functional-outcome for an anti-VEGF agent.

Marco A Beltran; Ruben Zamora-Alvarado; Roberto Gonzalez-Salinas; Rosario Gulias-Cañizo; Hugo Quiroz-Mercado; LUIS F HERNANDEZ; Hampar Karageozian; Vicken H Karageozian; John Y Park; Lenin Ochoa-de la Paz

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1465. doi:

ARVO Annual Meeting Abstract July 2018

Randomized, Prospective, Double-Masked, Controlled Phase 2b Trial to Evaluate the Safety & Efficacy of ALG-1001 (Luminate®) in Diabetic Macular Edema

Hugo Quiroz-Mercado; David S Boyer; Peter A Campochiaro; Jeffrey S. Heier; Peter K Kaiser; Julie Kornfield; Baruch D Kuppermann; Vicken H Karageozian; Hampar L Karageozian; Lisa Karageozian; John Y Park; Melvin Sarayba

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):1960. doi:

ARVO Annual Meeting Abstract June 2017

Topline results from prospective, double-masked, placebo controlled phase 2b clinical study evaluating Luminate ® in patients with diabetic macular edema

Peter K Kaiser; David S Boyer; Peter A Campochiaro; Jeffrey Heier; Julie Kornfield; Baruch D Kuppermann; Hugo Quiroz-Mercado; Lisa Karageozian; Linda Kutscher; Mary Karpus; John Y Park; Hampar L Karageozian; Vicken Karageozian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):2029. doi:

ARVO Annual Meeting Abstract June 2017

Integrin peptide inhibitor for the treatment of intermediate Age Related Macular Degeneration

Hugo Quiroz-Mercado; Jose Luis Guerrero-Naranjo; Roberto Gonzalez-Salinas; Luis F Hernandez-Zimbron; Ruben Zamora; Rosario Gulías-Cañizo; Lenin Ochoa-De la Paz; Lisa Karageozian; Vicken Karageozian; Linda Kutscher; John Y Park; Hampar Karageozian

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1943. doi:

ARVO Annual Meeting Abstract September 2016

Topline Results From Prospective, Double-masked, Placebo Controlled Phase 2 Clinical Study Evaluating Luminate ® (ALG-1001) in Patients with Symptomatic Focal Vitreomacular Adhesion

Baruch D Kuppermann; David S Boyer; Peter K Kaiser; Jeffrey S Heier; Peter A Campochiaro; Hugo Quiroz-Mercado; Julia Kornfield; Lisa Karageozian; Mohamed A Genead; Hampar L Karageozian; Vicken H Karageozian

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12) doi:

ARVO Annual Meeting Abstract March 2012

Intravitreal Injection of Integrin Peptide ALG-1001 for the Induction of Posterior Vitreous Detachment in Rabbit Eyes

Hugo E. Sepulveda-Vazquez; Jose Luis Guerrero-Naranjo; Fernando Schoonewolff; Hugo Quiroz-Mercado; Hampar L. Karageozian; John Y. Park; Vicken Karageozian; Sonia Corredor; Abelardo Rodriguez-Reyes; Marc Kirshbaum

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):5360. doi:

ARVO Annual Meeting Abstract March 2012

Integrin Peptide Therapy: A New Class of Treatment for Vascular Eye Diseases - The First Human Experience in DME

David S. Boyer; Hugo Quiroz-Mercado; Baruch D. Kuppermann; Julia Kornfield; Peter A. Campochiaro; Hampar L. Karageozian; Vicken Karageozian; John Park; Lisa Karageozian; Marc Kirshbaum

Invest. Ophthalmol. Vis. Sci.. 2012; 53(14):1337. doi:

« Previous

Advertisement

Follow @ARVOiovs

IOVS Home
Issues
Topics
For Authors
About
- Editorial Board
- Subscriptions

Online ISSN: 1552-5783

Investigative Ophthalmology & Visual Science
Journal of Vision
Translational Vision Science & Technology

JOURNALS HOME
TOPICS
ABOUT ARVO JOURNALS

Copyright © 2015 Association for Research in Vision and Ophthalmology.

Forgot password?

To View More...

Purchase this article with an account.

Create an Account

or

Subscribe Now

×

×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×

This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept